Orgenesis Inc. (NasdaqCM:ORGS) agreed to acquire 25% stake in Octomera LLC from MM OS Holdings, L.P. on January 31, 2024. In exchange, MM OS Holdings shall receive a royalty of 5% of the net revenue of Octomera?s cell processing services, for the three calendar years 2025-2027
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.609 USD | +5.00% | +17.12% | +21.63% |
04-16 | North American Morning Briefing : Powell Comments, -2- | DJ |
04-15 | Orgenesis Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+21.63% | 20.74M | |
-4.82% | 182B | |
+1.38% | 111B | |
-2.82% | 68.48B | |
+0.69% | 49.69B | |
+8.54% | 44.46B | |
+2.33% | 40.67B | |
+20.50% | 31.22B | |
+1.72% | 26.09B | |
+15.30% | 25.32B |
- Stock Market
- Equities
- ORGS Stock
- News Orgenesis Inc.
- Orgenesis Inc. agreed to acquire 25% stake in Octomera LLC from MM OS Holdings, L.P.